Skip to main content
. 2022 May 15;14(10):2072. doi: 10.3390/nu14102072

Figure 4.

Figure 4

Meta-analysis for a low-FODMAP diet and (a) the Gastrointestinal Symptom Rating Scale (GSRS), (b) the Irritable Bowel Syndrome–Symptom Severity System (IBS-SSS), (c) the Short IBD Questionnaire (SIBDQ), (d) the IBS Quality of Life (IBS-QoL) questionnaire in patients with inflammatory bowel disease.